3. INTRODUCTION
• POTASSIUM – most abundant intracellular
cation
• 98% intracellular (100-150 mEq/l) and 2%
extracellular (3- 5.5 mEq/l)
• Ratio of intra- to extracellular potassium
concentration determines, in large part, the
resting membrane potential (RMP)
• critical for normal function of electrically
excitable cells
4. • Goal of healthy human – ZERO potassium
balance
• Requirement 1- 2 mEq/kg through diet.
• About 85% of ingested potassium is absorbed.
• How to maintain 0 potassium balance??
• 90% excreted in urine and 10% in stools and
sweat
5. • robust somatic growth early in life requires
the maintenance - state of positive potassium
balance
• tendency to retain potassium early in
postnatal life is reflected-
higher plasma potassium values in infants and
particularly in preterm neonates.
• Active transport of potassium through
placenta
6.
7. • Only about 50% of ingested potassium is
excreted within 4-6 hrs by kidneys – long term
regulation, rest 40% slowly over weeks.
• How to handle excess potassium present in
diet then ??
• Life threatening hyperkalemia is not generally
observed
• Internal and external mechanisms of
potassium homeostasis
12. • Na-K-ATPase transports three sodium ions out
of and two potassium ions into the cell at the
expense of the hydrolysis of adenosine
triphosphate (ATP).
• The unequal cation exchange ratio produces a
charge imbalance across the cell membrane-
electrogenic pump.
13. • Positively charged potassium ions, present in
high concentration within the cell, passively
leak out of cells down a concentration
gradient through ubiquitously expressed
potassium-selective channels.
• A steady state is reached at which the
outward movement of positively charged
potassium is opposed by the negative cell
potential -RMP
14. Neonatology!!
• nonoliguric hyperkalemia- the first 72 h of
life
• serum potassium concentration >7.0 mEq/l, in
the presence of urinary output of >1 ml/kg/h,
despite the intake of negligible amounts of
potassium
• failure of the Na-K pump as well as a limited
secretory capacity of the kidney for potassium
• Prenatal steroid treatment – prevents
nonoliguric hyperkalemia via induction of Na-
K-ATPase activity
15. EFFECT OF ACIDOSIS AND
ALKOLOSIS ON POTASSIUM
• In organic acids – maximum effect
• Reduces activity of ATPase due to reduced
intracellular sodium.
• Abundant protons and depleted bicarb both
contribute
16. • Organic acids – utilize monocarboxylate
transportes and reduce intracellular pH.
Intracellular sodium is maintained by sodium
hydrogen exchanger and sodium bicarb
cotransporter.
17.
18. EFFECT OF INSULIN AND
CATECHOLAMINES ON POTASSIUM
• Insulin causes both insertion of ATPase and
GLUT 4 channels through diverse mechanisms.
• B agonists cause cAMP dependent increase of
ATPase
21. Case scenario
• 16 yrs old Preethi – admitted last month PICU
• Presented with vomiting, convulsions
• BP- 200/160, hypertensive emergency
• Past history significant with hypertension
diagnosed 1 yr back during appendicectomy
operation.
• Potassium – 1.9
• CT brain – changes suggestive of PRES
• CT angiogram – renal artery stenosis
31. • PCT - Active Na reabsorption drives net fluid
reabsorption across the proximal tubule, which
in turn, drives K reabsorption through a solvent
drag mechanism.
• Also permissive effect of shift in transepithelial
voltage
32.
33. • TALH - The basolateral Na-K-ATPase pump
maintains intracellular Na low, thus providing
a favorable gradient to drive the apically
located Na-K-2Cl cotransporter.
• The apically located renal outer medullary
(ROMK) channel provides a pathway for K to
recycle from cell to lumen, and ensures an
adequate supply of K to sustain Na-K-Cl2
cotransport
34.
35. • Aldosterone effect on ASDN
• Renovascular hypertension
• Monogenic forms of hypertension
50. Approach to hypokalemia
• Spurious – no electrocardiographic changes
• History and clinical examination- cause can be
discerned in most cases.
• Diarrhea, vomiting, drug intake, hypertension.
51. • Repeated measurement of blood pressure.
• Concurrent determination of the acid–base
balance, Na+, Cl−, Ca++, Mg++, urea and
creatinine.
• In normotensive subjects, the urinary
potassium/creatinine ratio distinguishes
hypokalemia due to a short-term shift of the ion
into cells (ratio <2.5 mol/mol) from hypokalemia
resulting due to a deficit of the ion(renal losses)
52. • In normotensive subjects with hypokalemia
and metabolic alkalosis, the urinary
chloride/creatinine ratio discriminates renal
from extrarenal (ratio <10 mol/mol) causes
54. • Formula used to assess renal handling of potassium.
• Adjusts the urinary potassium for the concentrating effects
that occur in the collecting tubule, where water is removed
from the urine.
• A high TTKG suggests that the kidney is wasting potassium,
which may be appropriate (in the setting of hyperkalemia) or
inappropriate (in the setting of hypokalemia).
• During hyperkalemia, the TTKG should be greater than 7;
lower values suggest hypoaldosteronism.
• During hypokalemia, the TTKG should be less than 3; greater
values suggest renal potassium wasting.
55. • The safest way to administer potassium is by mouth,
however
• Intestinal conditions that limit intake or absorption of K
• severe hypokalemia (<2.5 mmol/L),
• Characteristic electrocardiogram abnormalities (with or
without cardiac arrhythmias)
• respiratory muscle weakness
• anticipated shift of potassium into cells mandate
intravenous substitution
TREATMENT
56. • Primarily to deal with medical emergencies-
cardiac arrhtymias or resp failure to resp
muscle weakness. Goal is to raise K to more
than 3 mEq/l within 1 – 2 min. Rpt K after 10
min.
• Formula ( 3-measured K) *wt*0.04
(page no. 405 schaeffer)
• Next K is infused @ rate of 0.3 to 0.5
mEq/kg/hr for 2 hrs.
• Stock solution 90 ml NS with 10 ml KCl-
infused @ rate of 1.5 ml/kg/hr for 2 hrs.
57. • In cases of met acidosis with hypokalemia-
treat hypokalemia first.
• In conditions that require IV correction
without acute emergency- double or three
times more K can be added to maintenance
fluids.
• Consider cenrtal line for > 60 mEq/l
58. • Oral route – 2 to 3 mEq/kg/day in 3 divided
doses. Diluted with milk to prevent gastric
irritation.
• Resistant cases of hypokalemia- correct
hypomagnesemia. Reasons - ????
60. • So how do we treat Arun and Preethi ???
• Both had K < 2.5
• Both did not have cardiac arrhythmias or resp
muscle paralysis
• Hence …….
61. ARUN
• Cause – inadequate intake and malnutrition
• Started on IV potassium correction, 1.5
ml/kg/hr for 2 hrs and then when K levels
more than 2.5, 60 mEq/l given in maintenace
fluids for 48 hrs.
• Then later switched over to oral, given for 14
days as per SAM protocols.
62. • Nutrition – F 75 for 3 days, followed by
transition and F100.
• Edema started to reduce on day 3, discharged
on day 14 after admission.
63. PREETHI
• Cause –renovascular HTN
• IV correction for 12 hrs, later started on oral
potchlor.
• Persistent hypertension- not controlled with 3
antihypertensives.
• Girl was taken up for balloon angioplasty.
• First attempt was failure because of throbosis,
later next attempt given heparin infusion -
successful
64. • Antihypertensives tapered and stopped.
• Electrolytes normal on day 6
• Now BP normal by day 10, discharged
65.
66.
67.
68.
69.
70.
71.
72. REFERENCES
• SCHAEFFER – COMPREHENSIVE PAED
NEPHROLOGY
• AVNER’S PAED NEPHROLOGY
• NELSON 20 EDITION
• BAGGA NEPHROLOGY BOOK
• REGULATION OF POTASSIUM- CJASN EPRESS.
PUBLISHED ON MAY 1, 2014 AS DOI:
10.2215/CJN.08580813
• VIJAYKUMAR AND NAMMALWAR PAED
NEPHROLOGY